• Mashup Score: 0

    Young breast cancer (BC) patients carrying a germline BRCA pathogenic variant (mBRCA) have similar outcomes as non-carriers. However, the impact of the type of gene (BRCA1 vs. BRCA2) and hormone receptor status (positive [HR+] vs. negative [HR−]) on clinical behavior and outcomes of mBRCA BC remains largely unknown. This is an international, multicenter, hospital-based, retrospective cohort study…

    Tweet Tweets with this article
    • Excited to see in @Nature_NPJ our #SABCS20 data on clinical behavior & outcomes of #BreastCancer in #young women with germline #BRCA mutations: huge academic effort & important step to improve the care of these patients @OncoAlert #bcsm @SABCSSanAntonio https://t.co/6sp1aYtQn2 https://t.co/fGnZIxwgOs

  • Mashup Score: 2
    Wolters Kluwer Health - 3 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…

    Tweet Tweets with this article
    • More Advanced, Aggressive Breast Cancers at Presentation After #COVID19 https://t.co/fwhDtnm7UA #SABCS20 #cancer via @kpthrive https://t.co/kx7H0BFWhK

  • Mashup Score: 0

    Nadia Harbeck, MD, PhD, LMU Munich, Munich, Germany, discussing ongoing breast cancer clinical trials, including the ADAPT trial (NCT01779206), RxPONDER…

    Tweet Tweets with this article
    • VIDEO: Highlights from SABCS 2020 w/ Nadia Harbeck of @LMU_Meunchen 👉https://t.co/w3WoSmZGcL👈 @VJOncology @OncoAlert @SABCSSanAntonio #SABCS20 #OncoAlert #BCsm #BreastCancer

  • Mashup Score: 0

    Erika Hamilton, MD, Sarah Cannon Research Institute, Nashville, TN, discusses the next questions in the treatment and management of breast…

    Tweet Tweets with this article
    • VIDEO: Next questions in #BreastCancer treatment w/ @ErikaHamilton9 of @SarahCannonDocs 👉https://t.co/seFbbYwOUh👈 @VJOncology @OncoAlert @SABCSSanAntonio #SABCS20 #OncoAlert #BCsm

  • Mashup Score: 0

    Nadia Harbeck, MD, PhD, LMU Munich, Munich, Germany discusses the need for new drugs in the HER2-positive metastatic space in…

    Tweet Tweets with this article
    • VIDEO: Advances in #BreastCancer coming in 2021 w/ Nadia Harbeck of @LMU_Meunchen 👉https://t.co/eIHeKh1OCe👈 @VJOncology @OncoAlert @SABCSSanAntonio #SABCS20 #OncoAlert #BCsm #WorldCancerDay #IAmAndIWill